Treatment of human immunodeficiency virus-associated facial lipoatrophy with lipofilling and submalar silicone implants

Journal of Plastic, Reconstructive and Aesthetic Surgery

Volumn 59, Issue 11, 2006, Pages 1209-1216

  Mori, A ^a   Lo Russo, G ^a   Agostini, T ^a   Pattarino, J ^a   Vichi, F ^b   Dini, M ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

Facial lipoatrophy; HAART; HIV; Lipodystrophy; Lipofilling; Silicone malar implants

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED SURGERY; COMPUTER PROGRAM; DISEASE SEVERITY; ESTHETIC SURGERY; FACE DISORDER; FACE PROFILE; FACE SURGERY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPOATROPHY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SILICONE PROSTHESIS; SURGICAL TECHNIQUE; TREATMENT INDICATION;

ADIPOSE TISSUE; ADULT; CHEEK; FACE; FEMALE; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; RECONSTRUCTIVE SURGICAL PROCEDURES; SILICONE GELS; TREATMENT OUTCOME;

EID: 33749586736     PISSN: 17486815     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bjps.2005.12.047     Document Type: Article

References (44)

1. Carr A., Samaras K., Chisholm D.J., et al. Pathogenesis of HIV-1 protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 351 (1998) 1881-1883
2. Brinkman K., Smeitink J.A., Romijn J.A., et al. Mitochondrial toxicity induced by nucleoside-analogue-reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354 (1999) 1112-1115
3. Fliers E., Sauerwein H.P., Romijn J.A., et al. HIV-associated adipose redistribution syndrome as a selective autonomic neuropathy. Lancet 362 (2003) 1758-1760
4. Tershakovec M.A., Frank I., and Rader D. HIV-related lipodystrophy and related factors. Atherosclerosis 174 (2004) 1-10
5. Tien P.C., and Grunfeld C. What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection. Curr Opin Infect Dis 17 (2004) 27-32
6. Carr A., Emery S., Law M., et al. An objective case definition of lipodystrophy in HIV-infected adults: a case control study. Lancet 361 (2003) 726-735
7. McComsey G.A., Ward D.J., Hessenthaler S.M., et al. Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from Stavudine to Abacavir or Zidovudine: the result of the TARHEEL study. Clin Infect Dis 38 (2004) 263-270
8. Wohl D.A. Diagnosis and management of body morphology changes and lipid abnormalities associated with HIV infection and its therapies. Top HIV Med 12 (2004) 89-93
9. Talmor M., Hoffman L.A., and LaTrenta G.S. Facial atrophy in HIV-related fat redistribution syndrome: anatomic evaluation and surgical reconstruction. Ann Plast Surg 49 (2002) 11-17
10. Jackson I.T. Anatomy of the buccal fat pad and its clinical significance. Plast Reconstr Surg 103 (1999) 2059-2060 [discussion by Matarasso A.: 2061-3]
11. Coleman S.R. Long-term survival of fat transplants: controlled demonstrations. Aesthetic Plast Surg 19 (1995) 421-425
12. Coleman S.R. Facial recontouring with lipostructure. Clin Plast Surg 24 (1997) 347-367
13. James J., Carruthers A., and Carruthers J. HIV-associated facial lipoatrophy. Dermatol Surg 28 (2002) 979-986
14. Carr A., Samaras K., Burton S., et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12 (1998) F51-F58
15. Ridolfo A.L., Gervasoni C., Bini T., et al. Body habitus alteration in HIV-infected women treated with combined antiretroviral therapy. AIDS 14 (2000) 595-601
16. Dong K.L., Bausserman L.L., Flynn M.M., et al. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART). J Acquir Immune Defic Syndr 21 (1999) 107-113
17. Hadigan C., Miller K., Concoran C., et al. Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 84 (1999) 1932-1937
18. Koppel K., Bratt G., Eriksson M., et al. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection. Int J STD AIDS 11 (2000) 451-455
19. Hadigan C., Yawetz S., Thomas A., et al. Metabolic effects of rosiglitazone in HIV lipodystrophy. Ann Intern Med 140 (2004) 786-794
20. Martinez E., Garcia-Viejo M.A., Blanco J.L., et al. Impact of switching from human immunodeficiency virus type 1 protease inhibitors to efavirenz in successfully treated adults with lipodystrophy. Clin Infect Dis 31 (2000) 1266-1273
21. Domingo P., Matlas-Guiu X., Pujol R.M., et al. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 13 (1999) 2661-2667
22. Bogner J.R., Vielhauer V., Beckmann R.A., et al. Stavudine versus zidovudine and the development of lipodystrophy. J Acquir Immune Defic Syndr 27 (2001) 237-244
23. Papucci L., Schiavone N., Witort E., et al. Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 278 30 (2003) 28220-28228
24. Spadafora A., De los Rios E., and Toledo R.R. Flat cheeks. Polyethylene endoprostheses inserted subperiosteally along the zygomatic arch. Prensa Med Argent 58 (1971) 1946-1950
25. Hinderer U.T. Profileplasty. Int Micrform J Aesthet Plast Surg Card 1 No 1 (September 1971) (profiloplasty 1972-A)
26. Hinderer U.T. Malar implants for improvement of facial appearance. Plast Reconstr Surg 56 (1975) 157-165
27. Romo III T., Baskin J.Z., and Sclafani A.P. Augmentation of the cheeks, chin and pre-jowl sulcus, and nasolabial folds. Facial Plast Surg 17 (2001) 67-78
28. Orentreich D., and Leone A.S. A case of HIV-associated facial lipoatrophy treated with 1000-cs liquid injectable silicone. Dermatol Surg 30 (2004) 548-551
29. ® to correct facial lipoatrophy in HIV-infected patients: results of the open-label study VEGA. AIDS 17 (2003) 2471-2477
30. Boix V. Polylactic acid implants. A new smile for lipoatrophic faces?. AIDS 17 (2003) 2533-2535
31. Caye N., Le Fourn B., and Pannier M. Surgical treatment of facial lipoatrophy. Ann Chir Plast Esthet 48 (2003) 2-12
32. Strauch B., Baum T., and Robbins N. Treatment of human immunodeficiency virus-associated lipodystrophy with dermafat graft transfer to the malar area. Plast Reconstr Surg 113 (2004) 363-370
33. Wechselberger G., Sarcletti M., Meirer R., et al. Dermis-fat graft for facial lipodystrophy in HIV-positive patients: is a worthwhile?. Ann Plast Surg 47 (2001) 99-100
34. Levan P., Nguyen T.H., Lallemand F., et al. Correction of facial lipoatrophy in HIV-infected patients on highly active antiretroviral therapy by injection of autologous fatty tissue. AIDS 16 (2002) 1985-1987
35. Gueraldi G., De Fazio D., Orlando G., et al. Facial lipohypertrophy in HIV-infected subjects who underwent autologous fat tissue transplantation. Clin Infect Dis 40 (2005) e13-e15
36. Jabaley M.E., Hoopes J.E., and Cochran T.C. Transoral silastic augmentation of the malar region. Br J Plast Surg 27 (1974) 98-102
37. Metzinger S.E., McCollough E.G., Campbell J.P., et al. Malar augmentation. A 5-year retrospective review of the silastic midfacial malar implant. Arch Otolaryngol Head Neck Surg 125 (1999) 980-987
38. Mladick R.A. Alloplastic cheek augmentation. Clin Plast Surg 18 (1991) 29-38
39. Wilkinson T.S. Complications in aesthetic malar augmentation. Plast Reconstr Surg 71 (1983) 643-649
40. Ivy E.J., Lorenc Z.P., and Aston S.J. Malar augmentation with silicone implants. Plast Reconstr Surg 96 (1995) 63-68
41. Powell N.B., Riley R.W., and Lamb D.R. A new approach to evaluation and surgery of the malar complex. Ann Plast Surg 20 (1988) 206-214
42. Prendergast M., and Schoenrock L.D. Malar augmentation. Patient classification and placement. Arch Otolaryngol Head Neck Surg 115 (1989) 964-969
43. Silver W.E. Malar augmentation. Facial Plast Surg 3 (1992) 133-139
44. Costantinides M.S., Doud Galli S.K., Miller P.J., et al. Malar, submalar, and midfacial implants. Facial Plast Surg 16 (2000) 35-44